Article

Simvastatin-Mediated Nrf2 Activation Induces Fetal Hemoglobin and Antioxidant Enzyme Expression to Ameliorate the Phenotype of Sickle Cell Disease

2024-02-02

Abstract excerpt

Sickle cell disease (SCD) is a pathophysiological condition of chronic hemolysis, oxidative stress, and elevated inflammation. The transcription factor Nrf2 is a master regulator of oxidative stress. Here we reported that the FDA-approved, oral agent simvastatin, an inhibitor of hydroxymethyl-glutaryl coenzyme A reductase, significantly activates the expression of Nrf2 and antioxidant enzymes. Simvastatin also ind...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: b1a81422-27e1-5d0f-a759-a8ed52b4cb69
DOI: 10.20944/preprints202402.0091.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Simvastatin-Mediated Nrf2 Activation Induces Fetal Hemoglobin and Antioxidant Enzyme Expression to Ameliorate the Phenotype of Sickle Cell DiseaseDOI 10.20944/preprints202402.0091.v1Read

Loss of NRF2 function exacerbates the pathophysiology of sickle cell disease in a transgenic mouse model.Semantic proximity Read

Innovations in Drug Discovery for Sickle Cell Disease Targeting Oxidative Stress and NRF2 Activation – A Short ReviewSemantic proximity Read

Nrf2 sensitizes ferroptosis through L-2-hydroxyglutarate-mediated chromatin modifications in sickle cell diseaseSemantic proximity Read

Keap1-Nrf2 Heterodimer: A Therapeutic Target to Ameliorate Sickle Cell DiseaseSemantic proximity Read

Dimethyl fumarate increases fetal hemoglobin, provides heme detoxification, and corrects anemia in sickle cell diseaseSemantic proximity Read

microRNA miR-144 modulates oxidative stress tolerance and associates with anemia severity in sickle cell disease.Semantic proximity Read

NRF2 mediates γ-globin gene regulation and fetal hemoglobin induction in human erythroid progenitorsSemantic proximity Read

Simvastatin and t-butylhydroquinone suppress KLF1 and BCL11A gene expression and additively increase fetal hemoglobin in primary human erythroid cellsSemantic proximity Read

MIR-144-mediated NRF2 gene silencing inhibits fetal hemoglobin expression in sickle cell diseaseSemantic proximity Read

Ferroptosis as an emerging target in sickle cell diseaseSemantic proximity Read

Erythrophagocytes in hemolytic anemia, wound healing, and cancerSemantic proximity Read

Heme-stress activated NRF2 signaling skews fate trajectories of bone marrow cells from dendritic cells towards red pulp-like macrophagesSemantic proximity Read